Krystal Biotech buy Bank of America Co.
Start price
22.07.25
/
50%
€129.30
Target price
22.07.26
€164.24
Performance (%)
129.93%
Price
14.07.26
€297.30
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Krystal Biotech has seen massive gains of 129.93%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | -2.594% | -2.594% |
| iShares Core DAX® | -3,17 % | 1,23 % |
| iShares Nasdaq 100 | -1,01 % | 0,38 % |
| iShares Nikkei 225® | -3,60 % | 1,00 % |
| iShares S&P 500 | 0,21 % | 2,92 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Bank of America Corporation from $193.00 to $192.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€297.90
14.07.26
14.07.26
€347.61
14.07.27
14.07.27
-0.20%
14.07.26
14.07.26
Krystal Biotech
Start price
Target price
Perf. (%)
€246.10
22.01.26
22.01.26
€272.02
22.01.27
22.01.27
20.80%
14.07.26
14.07.26
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
86.86%
14.07.26
14.07.26